Prof. Dr. İMRAN VURAL

Yayın Ağı

Makaleler 96

1. Development of phytase targeted PLGA nanoparticles loaded with albendazole sulfoxide and praziquantel and evaluation of efficacy on the hydatid cysts

Gultekin Y., Korkmaz C., ÖZTÜRK N., FİLAZİ A., Deniz A., VURAL İ.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , 2025 (SCI-Expanded, Scopus)

2. Preparation and evaluation of fast-dissolving albendazole sulfoxide and praziquantel-loaded polyvinylpyrrolidone nanofiber films by electrospinning

Gültekin Y., Korkmaz Ç., ÖZTÜRK N., FİLAZİ A., Deniz A., Doğan O., et al.

Journal of Drug Delivery Science and Technology , cilt.92, 2024 (SCI-Expanded, Scopus)

3. Preparation of nanosuspensions of a 1,4-dihydropyridine-based mixed L-/T-type calcium channel blocker by combined precipitation and ultrasonication methods

PEZİK E., GÜLSÜN İNAL T., GÜNDÜZ M. G., ŞAHİN S., ÖZTÜRK N., VURAL İ.

Journal of Drug Delivery Science and Technology , cilt.87, 2023 (SCI-Expanded, Scopus)

4. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers

Nezir A. E., Bolat Z. B., ÖZTÜRK N., Kocak P., Zemheri E., Gulyuz S., et al.

Amino Acids , cilt.55, sa.8, ss.1023-1037, 2023 (SCI-Expanded, Scopus)

5. Preparation of nanodelivery systems for oral administration of low molecular weight heparin

Rüzgar Özemre G., KARA A., Pezik E., TORT S., VURAL İ., ACARTÜRK F.

Journal of Drug Delivery Science and Technology , cilt.79, 2023 (SCI-Expanded, Scopus)

6. Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug

ÖZDAL Z. D., Gültekin Y., VURAL İ., TAKKA S.

Journal of Drug Delivery Science and Technology , cilt.74, 2022 (SCI-Expanded, Scopus)

7. The Nanosuspension Formulations of Daidzein: Preparation and In Vitro Characterization

UĞUR KAPLAN A. B., ÖZTÜRK N., ÇETİN M., VURAL İ., ÖZNÜLÜER ÖZER T.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.19, sa.1, ss.84-92, 2022 (ESCI, Scopus, TRDizin)

8. Development of tumor-specific liposomes containing quantum dots-photosensitizer conjugate used for radiotherapy

Karabuga M., Erdogan S., Timur S. S., VURAL İ., calamak S., Ulubayram K.

JOURNAL OF LIPOSOME RESEARCH , cilt.32, sa.4, ss.396-404, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Simultaneous determination of albendazole sulfoxide and praziquantel from PLGA nanoparticles and validation of new HPLC method

Gültekin Y., ÖZTÜRK N., FİLAZİ A., Deniz A., Korkmaz Ç., Pezik E., et al.

Journal of Research in Pharmacy , cilt.26, sa.6, ss.1608-1618, 2022 (Scopus, TRDizin)

10. Poly(2-ethyl-2-oxazoline-co-ethyleneimine)-block-poly(epsilon-caprolactone) based micelles: synthesis, characterization, peptide conjugation and cytotoxic activity

Gulyuz S., Ozkose U. U., Khalily M. P., KESİCİ M. S., Kocak P., Bolat Z. B., et al.

NEW JOURNAL OF CHEMISTRY , cilt.45, ss.14532-14547, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Effect of precipitation inhibitors on supersaturation and solubility of furosemide

GÜLSÜN İNAL T., ÖZTÜRK N., Kara A., ŞAHİN S., VURAL İ.

JOURNAL OF RESEARCH IN PHARMACY , cilt.25, sa.2, ss.209-217, 2021 (ESCI, Scopus, TRDizin)

12. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate

PEZİK E., Gulsun T., ŞAHİN S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.156, 2021 (SCI-Expanded, Scopus)

13. Formulation and In Vitro Evaluation of Telmisartan Nanoparticles Prepared by Emulsion-Solvent Evaporation Technique

ÖZTÜRK N., KARA A., VURAL İ.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.5, ss.492-499, 2020 (ESCI, Scopus, TRDizin)

14. Exploiting ionisable nature of PEtOx-co-PEI to prepare pH sensitive, doxorubicin-loaded micelles

ÖZTÜRK N., KARA A., Gulyuz S., Ozkose U. U., TAŞDELEN M. A., BOZKIR A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.37, sa.7, ss.467-480, 2020 (SCI-Expanded, Scopus)

15. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment

AYTEKİN E., ÖZTÜRK N., Vurla İ., POLAT H. K., Cakmak H. B., ÇALIŞ S., et al.

Journal of Controlled Release , cilt.324, ss.238-249, 2020 (SCI-Expanded, Scopus)

16. Development of an Anti-Inflammatory Drug-Incorporated Biomimetic Scaffold for Corneal Tissue Engineering

Celebier S. K., Pehlivan S., DEMİRBİLEK M., Akinci M., VURAL İ., AKDAĞ ÇAYLI Y., et al.

Journal of Ocular Pharmacology and Therapeutics , cilt.36, sa.6, ss.433-446, 2020 (SCI-Expanded, Scopus)

17. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural İ., Karlı Oguz K., et al.

International Journal of Pharmaceutics , cilt.578, 2020 (SCI-Expanded, Scopus)

18. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles

Al-Heibshy F. N. S., BAŞARAN E., ARSLAN R., ÖZTÜRK N., VURAL İ., DEMİREL M.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.45, sa.10, ss.1635-1645, 2019 (SCI-Expanded, Scopus)

19. Floating drug delivery system of itraconazole: Formulation, in vitro and in vivo studies

Gokbulut E., VURAL İ., Asikoglu M., Ozdemir N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.49, ss.491-501, 2019 (SCI-Expanded, Scopus)

20. Preparation and characterization of furosemide nanosuspensions

GÜLSÜN İNAL T., Borna S. E., VURAL İ., ŞAHİN S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.93-100, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Development and characterization of gels and liposomes containing ovalbumin for nasal delivery

Kaplan M., Tugcu-Demiroz F., VURAL İ., Celebi N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.44, ss.108-117, 2018 (SCI-Expanded, Scopus)

22. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules

Yildiz S., AYTEKİN E., Yavuz B., Pehlivan S. B., VURAL İ., UNLU N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.5, ss.488-495, 2018 (SCI-Expanded, Scopus)

23. Development of novel self-assembled polymeric micelles from partially hydrolysed poly(2-ethyl-2-oxazoline)-co-PEI-b-PCL block copolymer as non-viral vectors for plasmid DNA in vitro transfection

Kara A., Ozturk N., ESENDAĞLI G., Ozkose U. U., Gulyuz S., Yilmaz O., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.46, 2018 (SCI-Expanded, Scopus)

24. A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles

SEKERDAG E., Lule S., PEHLIVAN S. B., Ozturk N., KARA A., KAFFASHI A., et al.

JOURNAL OF CONTROLLED RELEASE , cilt.261, ss.187-198, 2017 (SCI-Expanded, Scopus)

25. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.

Akdag C., SAHIN S., BUTTINI F., BALDUCCI A., MONTANARI S., VURAL I., et al.

Drug development and industrial pharmacy , cilt.43, ss.1378-1389, 2017 (SCI-Expanded, Scopus)

26. Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma

KAFFASHI A., Lule S., PEHLIVAN S. B., SARISOZEN C., VURAL İ., KOSUCU H., et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.69, sa.8, ss.1010-1021, 2017 (SCI-Expanded, Scopus)

27. Türk Farmakopesi Hazırlık Çalışmaları ve 26-28 Ocak 2017 Çeşme Çalıştayı

PALASKA E., VURAL İ., KOÇ F., ÖZDEMİRHAN M. E.

Türk Farmakope Dergisi , cilt.2, sa.1, ss.114-123, 2017 (Hakemli Dergi)

28. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies

DOGAN I. S., SARAC S., SARI S., KART D., Gokhan S. E., VURAL İ., et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.130, ss.124-138, 2017 (SCI-Expanded, Scopus)

29. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-I in Human Breast Cancer

TİMUR S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

PHARMACEUTICAL RESEARCH , cilt.34, sa.2, ss.352-364, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Evaluation of Antitumor Activity of a Non-Steroidal Anti-Inflammatory Drug, Ibuprofen, by a Targeted Nanoparticulate System

ÖZTÜRK N., KARA A., VURAL İ.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.36, sa.1, ss.44-52, 2017 (SCI-Expanded, Scopus)

31. In Vitro CNS Models

KARA A., ÖZTÜRK N., VURAL İ.

NANOTECHNOLOGY METHODS FOR NEUROLOGICAL DISEASES AND BRAIN TUMORS: DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER , ss.151-185, 2017 (SCI-Expanded)

32. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression

Gulsun T., Ozturk N., Kaynak M. S., Vural I., Sahin S.

Pharmazie , cilt.72, sa.7, ss.389-394, 2017 (SCI-Expanded, Scopus)

33. Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation

Yavuz B., Pehlivan S., Bolu B. S., Sanyal R. N., VURAL İ., UNLU N.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.68, sa.8, ss.1010-1020, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation

DEVRİM B., KARA A., VURAL İ., Bozkiir A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.42, sa.11, ss.1865-1876, 2016 (SCI-Expanded, Scopus)

35. In Vitro/In Vivo Evaluation of DexamethasonePAMAM Dendrimer Complexes for Retinal Drug Delivery

Yavuz B., Pehlivan S., VURAL İ., UNLU N.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.104, sa.11, ss.3814-3823, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application

PEHLIVAN S., Yavuz B., ÇALAMAK S., ULUBAYRAM K., KAFFASHI A., VURAL İ., et al.

Journal of Pharmaceutical Sciences , cilt.104, sa.5, ss.1709-1720, 2015 (SCI-Expanded, Scopus)

37. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies

Ocal H., Arica-Yegin B., VURAL İ., Goracinova K., ÇALIŞ S.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.40, sa.4, ss.560-567, 2014 (SCI-Expanded, Scopus)

38. Gen taşınması için olası bir yaklaşım Poli 2 oksazolin tabanlı vektörler

KARA A., VURAL İ., YILMAZ Ö., BOZKIR A.

Hacettepe University Journal of the Faculty of Pharmacy , 2014 (Scopus)

39. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.102, sa.10, ss.3748-3761, 2013 (SCI-Expanded, Scopus)

40. Preparation and characterization of nimesulide containing nanocrystal formulations

Gulsun T., Budak C., VURAL İ., ŞAHİN S., ÖNER L.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.18, sa.3, ss.653-659, 2013 (SCI-Expanded, Scopus)

41. Preparation and characterization of metformin hydrochloride loaded-Eudragit (R) RSPO and Eudragit (R) RSPO/PLGA nanoparticles

ÇETİN M., ATİLA A., ŞAHİN S., VURAL İ.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.18, sa.3, ss.570-576, 2013 (SCI-Expanded, Scopus)

42. In vitro studies on 5-florouracil-loaded DTPA-PE containing nanosized pegylated liposomes for diagnosis and treatment of tumor

Liko F., ERDOĞAN S., Ozer Y. A., VURAL İ.

JOURNAL OF LIPOSOME RESEARCH , cilt.23, sa.1, ss.61-69, 2013 (SCI-Expanded, Scopus)

43. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression

OLMEZ S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

PHARMAZIE , cilt.68, sa.2, ss.110-116, 2013 (SCI-Expanded, Scopus)

44. Formulation and in vitro evaluation of paclitaxel loaded nanoparticles Paklitaksel yüklü nanopartiküllerin formülasyonu ve in vitro incelenmesi

Aygül G., Yerlikaya F., Caban S., VURAL İ., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.25-40, 2013 (Scopus)

45. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance

Sarisozen C., VURAL İ., Levchenko T., Hincal A. A., Torchilin V. P.

DRUG DELIVERY , cilt.19, sa.8, ss.363-370, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Reversal of multidrug resistance by antibody targeted micelles

Sarisozen C., VURAL İ., Hincal A. A., Torchilin V. P.

NEW BIOTECHNOLOGY , cilt.29, 2012 (SCI-Expanded, Scopus)

47. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells

Sarisozen C., VURAL İ., Levchenko T., Hincal A. A., Torchilin V. P.

DRUG DELIVERY , cilt.19, sa.4, ss.169-176, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells

Mut M., Lule S., Demir O., Kurnaz I. A., VURAL İ.

International Journal of Biochemistry and Cell Biology , cilt.44, sa.2, ss.302-310, 2012 (SCI-Expanded, Scopus)

49. Salmon calcitonin-loaded Eudragit (R) and Eudragit (R)-PLGA nanoparticles: in vitro and in vivo evaluation

ÇETİN M., AKTAŞ M. S., VURAL İ., Ozturk M.

JOURNAL OF MICROENCAPSULATION , cilt.29, sa.2, ss.156-166, 2012 (SCI-Expanded, Scopus)

50. CHARACTERIZATION, CELL PROLIFERATION AND CYTOTOXICITY EVALUATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR LOADED POLY (LACTIC-CO-GLYCOLIC ACID) MICROSPHERES

KERİMOĞLU O., ALARÇİN E., Turkoglu M., Dortunc B., Karagoz H., Ulkur E., et al.

NOBEL MEDICUS , cilt.8, sa.1, ss.77-82, 2012 (SCI-Expanded, Scopus)

51. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells

ZEYBEK N. D., Gulcelik N. E., KAYMAZ F. F., Sarisozen C., VURAL İ., BODUR E., et al.

JOURNAL OF ENDOCRINOLOGY , cilt.210, sa.1, ss.105-115, 2011 (SCI-Expanded, Scopus)

52. Chitosan Coated Furosemide Liposomes for Improved Bioavailability

VURAL İ., Sarisozen C., Olmez S. S.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY , cilt.7, sa.3, ss.426-430, 2011 (SCI-Expanded, Scopus)

53. Rapamycin-cyclodextrin complexation: Improved solubility and dissolution rate

Abdur Rouf M., VURAL İ., BİLENSOY E., Hincal A., Erol D. D.

Journal of Inclusion Phenomena and Macrocyclic Chemistry , cilt.70, ss.167-175, 2011 (SCI-Expanded)

54. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets

Bozdag-Pehlivan S., Subasi B., VURAL İ., Unlu N., ÇAPAN Y.

Acta Poloniae Pharmaceutica - Drug Research , cilt.68, sa.3, ss.423-433, 2011 (SCI-Expanded, Scopus)

55. Orally disintegrating tablets ii: In vitro and in vivo evaluations Aǧızda daǧılan tabletler ii: In vitro ve in vivo deǧerlendirilmeleri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.31, sa.1, ss.59-70, 2011 (Scopus)

56. An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies.

Yavuz B., Sarisözen C., Vural İ., Bilensoy E., Sumnu M.

Journal of controlled release : official journal of the Controlled Release Society , cilt.148, sa.1, 2010 (SCI-Expanded, Scopus)

57. Alternative oral exemestane formulation: Improved dissolution and permeation

Yavuz B., BİLENSOY E., VURAL İ., Sumnu M.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.398, ss.137-145, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Orally disintegrating tablets i: Preparation technologies Aǧizda daǧilan tabletler i: Hazirlama teknolojileri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.30, sa.2, ss.205-230, 2010 (Scopus)

59. Preparation and characterization of anticancer drug-loaded implantable PLGA microparticles

ÇETİN M., VURAL İ., ATİLA A., Kadioglu Y.

TURKISH JOURNAL OF CHEMISTRY , cilt.34, sa.4, ss.509-516, 2010 (SCI-Expanded, Scopus, TRDizin)

60. Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells

Rouf M. A., VURAL İ., Renoir J. M., Hincal A. A.

JOURNAL OF LIPOSOME RESEARCH , cilt.19, sa.4, ss.322-331, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Advantages and quality control of orally disintegrating tablets

Ölmez S. S., VURAL İ.

Fabad Journal of Pharmaceutical Sciences , cilt.34, sa.3, ss.167-172, 2009 (Scopus)

62. PREPARATION OF FAMOTIDINE ORALLY DISINTEGRATING TABLETS

Olmez S. S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.65-66, 2009 (SCI-Expanded)

63. CHITOSAN COATED LIPOSOMES LOADED WITH FUROSEMIDE: CHARACTERIZATION AND CELLULAR INTERACTION

Sarisozen C., Olmez S. S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.82-83, 2009 (SCI-Expanded)

64. DEVELOPMENT AND CHARACTERIZATION OF THEOPHYLLINE LOADED PLGA MICROSPHERES

Shamil D., Sarisozen C., Pehlivan S. B., Basit A., ŞAHİN S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.96-97, 2009 (SCI-Expanded)

65. FORMULATION AND IN VITRO EVALUATION OF EUDRAGIT-L100/PLGA NANOPARTICLES CONTAINING SALMON CALCITONIN

ÇETİN M., VURAL İ., ATİLA A., Sarisozen C., KADIOĞLU Y.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.85-86, 2009 (SCI-Expanded)

66. PEG-PE BASED MIXED MICELLES LOADED WITH PACLITAXEL FOR ANTITUMOR ACTIVITY: ENHANCED DRUG SOLUBILIZATION

Sarisozen C., VURAL İ., Torchilin V. P., Hincal A. A.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.83-84, 2009 (SCI-Expanded)

67. Microbiological and clinical comparison of chlorhexidine buccoadhesive tablet and chlorhexidine mouthrinse

AKTAŞ A., GIRAY B., ÇAPAN Y., MENEMENLIOGLU D., HAYRAN M., IKINCI G., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.19, sa.5, ss.353-357, 2009 (SCI-Expanded, Scopus)

68. Hyaluronic acid coated poly-ε-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea

Yenice I., Mocan M. C., PALASKA E., Bochot A., BİLENSOY E., VURAL İ., et al.

Experimental Eye Research , cilt.87, sa.3, ss.162-167, 2008 (SCI-Expanded, Scopus)

69. Preparation and characterization of BSA-loaded alginate microspheres

ÇETİN M., VURAL İ., ÇAPAN Y., Hincal A. A.

Fabad Journal of Pharmaceutical Sciences , cilt.32, sa.3, ss.103-107, 2007 (Scopus)

70. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles

Cetin M., Aktas Y., Vural İ., Capan Y., Dogan L. A., Duman M., et al.

DRUG DELIVERY , cilt.14, sa.8, ss.525-529, 2007 (SCI-Expanded, Scopus)

71. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres

Yemisci M., Vural İ., Bozdag S., Cetin M., Soylemezoglu F., Capan Y., et al.

Neurosurgery , cilt.59, sa.6, ss.1296-1302, 2006 (SCI-Expanded, Scopus)

72. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

Bilensoy E., Rouf M. A., Vural İ., Sen M., Hincal A. A.

AAPS PharmSciTech , cilt.7, sa.2, 2006 (SCI-Expanded, Scopus)

73. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.

BİLENSOY E., Rouf M., VURAL İ., Hincal A.

Journal of controlled release : official journal of the Controlled Release Society , cilt.116, sa.2, 2006 (SCI-Expanded, Scopus)

74. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

KİLİC A. C., Capan Y., Vural I., Gursoy R. N., Dalkara T., CUİNE A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.22, sa.6, ss.633-641, 2005 (SCI-Expanded, Scopus)

75. Preparation and characterization of bFGF and BSA-loaded microspheres

Cetin M., Capan Y., Vural I., Dogan A., Guc D., Hincal A., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.15, sa.5, ss.371-375, 2005 (SCI-Expanded, Scopus)

76. Transcription efficiency of tamoxifen citrate-loaded beta-cyclodextrin nanoparticles

Vural I., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchene D., Hincal A.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.15, sa.5, ss.339-342, 2005 (SCI-Expanded, Scopus)

77. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity

Memisoglu-Bilensoy E., VURAL İ., Bochot A., Renoir J. M., Duchene D., Hincal A. A.

Journal of Controlled Release , cilt.104, sa.3, ss.489-496, 2005 (SCI-Expanded, Scopus)

78. Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells

Bozdag S., Capan B., Vural I., Dalkara T., Dogan A., Guc D., et al.

Journal of Drug Delivery Science and Technology , cilt.15, sa.3, ss.201-206, 2005 (SCI-Expanded, Scopus)

79. Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles

VURAL İ., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchêne D., Hincal A.

Journal of Drug Delivery Science and Technology , cilt.15, sa.5, ss.339-342, 2005 (SCI-Expanded, Scopus)

80. In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells.

Bozdag S., Capan Y., Vural I., Dalkara T., Dogan A., Guc D., et al.

Journal of microencapsulation , cilt.21, sa.7, ss.751-60, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. Method Validation in Determination of Mitoxantrone by HPLC

Bozdaǧ S., ÇAPAN Y., VURAL İ., Hincal A. A.

Acta Pharmaceutica Turcica , cilt.46, sa.1, ss.43-47, 2004 (Scopus)

82. Mitoxantrone loaded poly(DL-lactide-co-glycolide) microspheres for treatment of brain tumors I. formulation and release characteristics

Bozdaǧ S., ÇAPAN Y., VURAL İ., Hincal A., DeLuca P.

Technology and Health Care , cilt.10, ss.353-355, 2002 (SCI-Expanded, Scopus)

83. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes

Khaw B., da Silva J., Vural İ., Narula J., Torchilin V.

JOURNAL OF CONTROLLED RELEASE , cilt.75, ss.199-210, 2001 (SCI-Expanded, Scopus)

84. Use of cytoskeleton-specific immunoliposomes for preservation of cell viability and gene delivery

Khaw B., Vural İ., DaSilva J., Torchilin V.

S.T.P. Pharma Sciences , cilt.10, sa.4, ss.279-283, 2000 (SCI-Expanded, Scopus)

85. Comparative efficiencies of transfection by cationic liposomes and cytoskeleton specific immunolipomes

Khaw B., Vural İ., Narula J., Torchilin V.

Proceedings of the Controlled Release Society , sa.26, ss.216-217, 1999 (Scopus)

86. Intracytoplasmic delivery of plasmid pGL2 vector by cytoskeleton specific immunolipome transfection

Khaw B., Vural İ., Torchilin V., Narula J.

Proceedings of the Controlled Release Society , sa.25, ss.178-179, 1998 (Scopus)

87. Preservation of cardiocyte viability by immunoliposome-cell membrane sealing at 1, 2, 3, 4 and 5 days of hypoxia

Khaw B., Vural İ., Narula J., Haider N., Torchilin V.

Proceedings of the Controlled Release Society , sa.23, ss.617-618, 1996 (Scopus)

88. Expression of antimyosin sFv gene in cardiocytes: Use of cytoskeleton-specific immunoliposomes for transfection

Khaw B., Vural İ., Torchilin V., Haider N., Narula J.

Proceedings of the Controlled Release Society , sa.23, ss.135-136, 1996 (Scopus)

89. PLUG AND SEAL - PREVENTION OF HYPOXIC CARDIOCYTE DEATH BY SEALING MEMBRANE LESIONS WITH ANTIMYOSIN-LIPOSOMES

KHAW B., TORCHILIN V., VURAL İ., NARULA J.

NATURE MEDICINE , cilt.1, sa.11, ss.1195-1198, 1995 (SCI-Expanded, Scopus)

90. A method for targeted intracellular delivery of drugs and genes: A novel utilization of immunoliposomes

Vural İ., Narula J., Torchilin V., Khaw B.

Proceedings of the Controlled Release Society , sa.22, ss.450-451, 1995 (Scopus)

91. Targeted sealing of cell membrane lesions: Model of preservation of cell viability by immunoliposome therapy

Khaw B., Vural İ., Narula J., Torchilin V.

Proceedings of the Controlled Release Society , sa.22, ss.184-185, 1995 (Scopus)

92. EFFECT OF ENCAPSULATION OF CHLORAMPHENICOL IN ALBUMIN MICROSPHERES ON ITS IN-VITRO TRANSFER ACROSS THE HUMAN PLACENTA

ONUR M., VURAL İ., BASCI N. E., PAMIR R., COSKUN T., ISIMER A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.11, sa.6, ss.657-662, 1994 (SCI-Expanded, Scopus)

93. Quantitation of specific targeting of antimyosin immuno liposomes to necrotic myoblast cells

Vural İ., Torchilin V., Narula J., Khaw B.

Proceedings of the Controlled Release Society , sa.21, ss.226-227, 1994 (Scopus)

94. Cyclophosphamide loaded albumin microspheres. IV. Application of factorial design

VURAL İ., Kas H., ÖNER L., Hincal A.

S.T.P. Pharma Sciences , cilt.1, sa.5, ss.318-320, 1991 (SCI-Expanded, Scopus)

95. CYCLOPHOSPHAMIDE LOADED ALBUMIN MICROSPHERES .2. RELEASE CHARACTERISTICS

VURAL İ., KAS H., HINCAL A., CAVE G.

JOURNAL OF MICROENCAPSULATION , cilt.7, sa.4, ss.511-516, 1990 (SCI-Expanded, Scopus)

96. CYCLOPHOSPHAMIDE LOADED ALBUMIN MICROSPHERES - LIVER ENTRAPMENT AND FATE IN MICE

VURAL İ., KAS H., ERCAN M., HINCAL A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.16, sa.11, ss.1781-1789, 1990 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 51

1. EVALUATION OF DUAL EFFECT OF SODIUM BOROHYDRIDE (NaBH4) AS A REDUCING AND CROSSLINKING AGENT FOR DEVELOPMENT OF SILVER NANOPARTICLES (AgNPs) LOADED CHITOSAN-POLY(VINYL ALCOHOL)(CS-PVA) HYDROGELS

KARA A., ÖZTÜRK N., VURAL İ.

8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

2. Determınatıon of Equılıbrıum Solubılıty of Lamotrıgıne Usıng UV Spectrophotometer

Pezik E., Şahin S., Vural İ.

International Multidisciplinary Symposium on Drug Research Development (DRD 2019), Malatya, Türkiye, 1 - 03 Temmuz 2019, ss.367-370, (Tam Metin Bildiri)

3. PREPARATION AND CHARACTERIZATION OF DOCETAXEL LOADED POLYMERIC MICELLES

ÖZTÜRK N., KARA A., ÖZKÖSE U. U., Gulyuz S., Yilmaz O., BOZKIR A., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)

4. EVALUATION OF STEALTH PROPERTIES OF PEtOx BASED MICELLE/GENE COMPLEXES BY STABILITY STUDIES

KARA A., ÖZTÜRK N., Gulyuz S., ÖZKÖSE U. U., bolat z. b., Yilmaz O., et al.

IPTS 2018, 17 - 19 Eylül 2018, (Özet Bildiri)

5. APOPTOTIC GENE THERAPY BY NOVEL DEVELOPED PARTIALLY HYDROLYSED PEtOx BASED MICELLAR NANOCARRIERS ON MCF-7 BREAST CANCER CELLS

KARA A., ÖZTÜRK N., ESENDAĞLI G., ÖZKÖSE U. U., Gulyuz S., bolat z. b., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Effect Of Lamotrigine On Viability Of MCF-7 And RG-2 Cells

Pezik E., Öztürk N., Çeliker A., Şahin S., Vural İ.

19th International Pharmaceutical Technology Symposium (IPTS 2018) , Antalya, Türkiye, 17 - 19 Eylül 2018, ss.212-213, (Tam Metin Bildiri)

7. IN VITRO EVALUATION OF pH SENSITIVE DOXORUBICIN LOADED MICELLES

ÖZTÜRK N., KARA A., ÖZKÖSE U. U., Gulyuz S., Yilmaz O., BOZKIR A., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)

8. Investigation of Cytotoxic Effects of Daidzein and Levetiracetam on RG2 Glioma Cell Line

ÖZTÜRK N., UĞUR A. B., ÇETİN M., VURAL İ.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, ss.176-177, (Tam Metin Bildiri)

9. ffloating drug delivery system of ıtraconazole :formulation,invitro and in vivo studies

Gökbulut E., VURAL İ., AŞIKOĞLU M., ÖZDEMİR A. N.

ISOPS 12 th ınternational symposium on pharmaceutivcal sciences, 26 - 29 Haziran 2018, (Tam Metin Bildiri)

10. Determination of cytotoxicity of Lamotrigine on L929 cell line.

Pezik E., Öztürk N., Şahin S., Vural İ.

12 th International Symposium on Pharmaceutical Sciences (ISOPS 2018), Ankara, Türkiye, 26 - 29 Haziran 2018, ss.295-296, (Özet Bildiri)

11. Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma

Sekerdag E., LULE S., PEHLİVAN S., KARA A., OZTURK N., KAFFASHI A., et al.

23rd World Congress of Neurology (WCN), Kyoto, Japonya, 16 - 21 Eylül 2017, cilt.381, ss.171-172, (Özet Bildiri)

12. IN VITRO PERMEATION STUDY FOR ORALLY DISINTEGRATINGTABLETS CONTAINING MIRTAZAPINE

yıldız s., AYTEKİN E., YAVUZ B., PEHLİVAN S., VURAL İ., Ünlü N.

2nd İnternational Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

13. Pullulan Based Orally Dısıntegratıng Fılms of Telmısartan

Öztürk N., Pezik E., Kara A., Vural İ.

2nd International Gazi Symposium Series (GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

14. DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-DELIVERY SYSTEM BASED ON DEXAMETHASONE SODIUM PHOSPHATE (DEX-NP) LOADED CHITOSAN WITH PLASMID DNA

KARA A., ÖZTÜRK N., VURAL İ.

2nd INTERNATIONAL GPSS Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

15. THE BIODISTRIBUTION OF FARNESYLTHIOSALICYLIC ACIDINCORPORATED HYBRID NANOPARTICLES FOLLOWINGINTRANASAL ADMINISTRATION IN RATS

ŞEKERDAĞ E., LÜLE S., PEHLİVAN S., ÖZTÜRK N., KARA A., KAFFASHİ A., et al.

2nd International Gazi Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

16. Orally Dısıntegratıng Tablets of Telmısartan; Formulatıon Development and Evaluatıon

Pezik E., Öztürk N., Vural İ.

2nd International Gazi Symposium Series (GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

17. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

International Multidisciplinary Symposium on Drug Research and Development (DRD-2017), 5 - 07 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.

1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

19. In vitro CACO-2 cell permeability studies of ritonavir nanosuspension formulation

KARAKÜÇÜK A. E., ÖZTÜRK N., VURAL İ., TEKSİN Z. Ş., ÇELEBİ F. N.

6th FIP Pharmaceutical Sciences World Congress 2017, 21 - 24 Mayıs 2017, (Özet Bildiri)

20. Evaluation of Morphological and Physical Characteristics of Poly (2-Ethyl -2-Oxazoline)-co- Poly(Ethylenimine)-block-Poly(€-Caprolactone)(PetOx-co-PEI-b-PCL)Polymeric Micelle as a Gene Delivery Agent

KARA A., ÖZTÜRK N., ÖZKÖSE U., Bolat Z. B., Yılmaz Ö., TELCİ D., et al.

AAPS 2017, San Diego, Amerika Birleşik Devletleri, 1 - 03 Mayıs 2017, (Özet Bildiri)

21. EVALUATION OF MORPHOLOGICAL AND PHYSICAL CHARACTERISTICS OF Poly (2-Ethyl-2-Oxazoline)-co-Poly(Ethylenimine)-block-Poly(ɛ-Caprolactone)(PEtOx-co-PEI-b-PCL) POLYMERIC MICELLE AS A GENE DELIVERY AGENT

KARA A., ÖZTÜRK N., ÖZKÖSE U., BOLAT Z. B., YILMAZ Ö., TELCİ D., et al.

AAPS 2017 NATIONAL BIOTECHNOLOGY, San Diego, Amerika Birleşik Devletleri, 1 - 03 Mayıs 2017, (Özet Bildiri)

22. NOVEL POLYMERIC MICELLES BASED ON Poly-(2-Ethyl-2-Oxazoline)-co-Poly(ethylenimine)-block-Poly(ɛ-caprolactone) PEtOx-co-PEI-b-PCL BLOCK COPOLYMER WITH VARIOUS HYDROLYSIS DEGREE TO EVALUATE THE EFFECT OF TRANSFECTION EFFICIENCY ON MCF-7 CELLS

KARA A., ÖZTÜRK N., ESENDAĞLI G., BOLAT z. b., GÜLYÜZ s., TELCİ D., et al.

AAPS 2017 NATIONAL BIOTECHNOLOGY CONGRESS, San Diego, Amerika Birleşik Devletleri, 01 Mayıs 2107 - 03 Mayıs 2017, (Özet Bildiri)

23. Türk Farmakopesinde Majistraller

VURAL İ.

Türk Farmakopesi Çalıştayı, Türkiye, 26 - 28 Ocak 2017

24. Levofloxacin Dry Powder for Inhalation by Spray Drying Method

AKDAĞ ÇAYLI Y., ŞAHİN S., Buttini F., Balducci A. G., Montanari S., VURAL İ., et al.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

25. Development and Validation of an HPLC method for Simultaneous Determination of Ciprofloxacin Levofloxacin and N acetylcysteine

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

26. Determination of Permeability of Ciprofloxacin Dry Powder Inhaler Formulations Across Calu 3 Cell Line

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

27. Determination and Evaluation of Aerodynamic Parameters of Ciprofloxacin and Mucolytic Containing Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., BUTTINI F., BALDUCCI A. G., MONTANARI S., VURAL İ., et al.

The Globalization of Pharmaceutics Education Network (GPEN) 2016, 9 - 12 Kasım 2016, (Özet Bildiri)

28. Determination of Itraconazole from Caco 2 Cells Using High Performance Liquid Chromatography

Gökbulut E., VURAL İ., ÖZDEMİR A. N.

10th Aegean Analytical Chemistry Days, 29 Eylül - 02 Ekim 2016

29. Dissolution profiles of fosinopril sodium orodispersible tablets and orodispersible films

ŞAHİN G., ÖZTÜRK N., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

30. Investigation of anti tumor effect of telmisartan loaded poly d l lactide nanoparticles on mcf 7 cells

ÖZTÜRK N., KARA A., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

31. Micellar characteristics of poly 2 ethyl 2 oxazoline co poly ethylenimine block poly caprolactone petox co peı b pcl block copolymers of different hydrolysis degrees of PEtOx

KARA A., ÖZTÜRK N., GÜLYÜZ S., ÖZKÖSE U. U., VURAL İ., YILMAZ Ö., et al.

18th IPTS, 18 - 21 Eylül 2016

32. In vitro evaluation of dexamethasone sodium phosphate dex np loaded chitosan nanoparticles as an antitumor agent on mcf 7 cell line

KARA A., ÖZTÜRK N., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

33. EVALUATION OF PERMEABILITY OF LEVOFLOXACIN CONTAINING DRY POWDER INHALER ACROSS CALU 3 CELL LINE

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

34. Potential of Peptide Drug Conjugates for Targeted Breast Cancer Therapy

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

2016 AAPS National Biotechnology Conference, 16 - 18 Mayıs 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

35. Formulation and Characterization of Ciprofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015, (Özet Bildiri)

36. Formulation and Characterization of Levofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

3rd International TB-Meeting, 14 - 16 Ekim 2015, (Tam Metin Bildiri)

37. Formulation and Characterization of Antibiotic and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

1st European Conference on Pharmaceutics : Drug Delivery, 13 - 14 Nisan 2015

38. Formulation and In Vitro Evaluation of Furosemide Nanosuspensions

GÜLSÜN İNAL T., sahand ebadi b., VURAL İ., ŞAHİN S.

1st European Conference on Pharmaceutics : Drug Delivery, Reims, Fransa, 13 - 14 Nisan 2015, (Özet Bildiri)

39. Preparation and Evaluation of Furosemide Containing Orally Disintegrating Tablets by Direct Compression

GÜLSÜN İNAL T., ÖZTÜRK N., KAYNAK M. S., ŞAHİN S., VURAL İ.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

40. Effect of Precipitation Inhibitors on Supersaturation and Solubility of Furosemide

ÖZTÜRK N., KARA A., GÜLSÜN İNAL T., PEHLİVAN S., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

41. Development of Orally Disintegrating Tablets Containing Olmesartan Medoxomil and Amlodipine Besylate

ÖZTÜRK N., GÜLSÜN İNAL T., KAYNAK M. S., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

42. Effect of Milling Time on the Formulation Parameters of Nanosuspensions

GÜLSÜN İNAL T., ÖZTÜRK N., PEHLİVAN S., ŞAHİN S., VURAL İ.

AAPS Annual Meeting and Exposition, San diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

43. Preparation and In vitro Evaluation of Furosemide Nanosuspensions for Enhancement of its Solubility and Permeability

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

17th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 8 - 10 Eylül 2014, (Özet Bildiri)

44. Comparison of Furosemide Nanocrystals and Nanosuspensions in Terms of Solubility and Permeability

ÖZTÜRK N., GÜLSÜN İNAL T., ŞAHİN S., VURAL İ.

17th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 8 - 10 Eylül 2014, (Özet Bildiri)

45. Formulation and Characterization of Ciprofloxacin Nanoparticles for Use in Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

17th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014, (Tam Metin Bildiri)

46. Preparation and Characterization of Furosemide Nanosuspensions

sahand ebadi b., GÜLSÜN İNAL T., GÜRSOY R. N., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, chicago, Amerika Birleşik Devletleri, 14 - 18 Ekim 2012, (Özet Bildiri)

47. Preparation of Furosemide Nanosuspensions by High Pressure Homogenization and Its In vivo Characterization

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

16th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 10 - 12 Eylül 2012, (Özet Bildiri)

48. Enhancement of Solubility of Nimesulide by Preparing Nanocrystal Formulation

çisem b., GÜLSÜN İNAL T., VURAL İ., ŞAHİN S., ÖNER L.

Globalization of Pharmaceutics Education Network: Eighth Meeting, chapel hill, 10 - 12 Kasım 2010

49. Preparation and Characterization of Basic Fibroblast Growth Factor (bFGF)-Loaded Microparticulate Drug Delivery Systems,

ÇETİN M., ÇAPAN Y., VURAL İ., GÜRSOY R. N., DALKARA T., Cuine A., et al.

2004 AAPS Annual Meeting and Exposition, Maryland, Amerika Birleşik Devletleri, 31 Ekim 2004, (Tam Metin Bildiri)

50. Preservation of cardiocyte viability by immunoliposome-cell membrane sealing at 1, 2, 3, 4 and 5 days of hypoxia.

Khaw B., Vural İ., Narula J., Haider N., Torchilin V.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japonya, 7 - 10 Temmuz 1996, ss.617-618, (Tam Metin Bildiri)

51. Expression of antimyosin sFv gene in cardiocytes: Use of cytoskeleton-specific immunoliposomes for transfection.

Khaw B., Vural İ., Torchilin V., Haider N., Narula J.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japonya, 7 - 10 Temmuz 1996, ss.135-136, (Tam Metin Bildiri)

Metrikler

Yayın

160

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1481

H-İndeks (WoS)

Atıf (Scopus)

1801

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın